Covigilant Research, LLC

Committed To Working Together

Iowa reports another 138 COVID-19 deaths, 1158 confirmed coronavirus cases

December 20, 2020 December 20, 2020

COVID-19 is the disease caused by the coronavirus. The state was reporting at 10 a.m. Sunday that there are 267,144 confirmed cases of coronavirus, …Read More

Biophytis Announces Public Filing of a Registration Statement for Proposed Initial Public Offering in the United States
on January 19, 2021
All securities to be sold in the ADS Offering would be offered by Biophytis. The proposed maximum aggregate offering price is currently estimated at US$14,950,000 for the purposes of the registration ...
Clene Nanomedicine Receives Patent Notice of Allowance in the United States for using Gold ...
on January 19, 2021
Resulting patent to cover methods of using Clene’s lead candidate CNM-Au8, now in Phase 2 and 3 trials for Multiple Sclerosis (MS) and Amyotrophic lateral sclerosis (ALS) Latest patent allowance adds ...
Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead ...
on January 19, 2021
Lixte has partnered with top medical institutions and leading academic research centers to advance the clinical development of its compounds ... with the Company’s filings with the United States ...
Withings Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
on January 19, 2021
Boston, MA, United States, 2021/01/19 - New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research Launches - DTRA.org / ...
Global Clinical Trials Consumables Market 2021 Segmentation and Analysis by Recent Trends, Development and Growth by Trending Regions by 2026
on January 19, 2021
Final Report will add the analysis of the impact of COVID-19 on this industry." Global “ Clinical Trials Consumables Market ” report 2021 gives complete research on market size in the form of value, ...
United States Smoking Cessation Market Analysis 2021: Treatment Options, Pipeline Products, Key Products Marketed, Market Valuations and Forecasts
on January 18, 2021
1. Smoking Cessation Phase 3 Clinical Trials, 2021 2. Smoking Cessation Phase 2 Clinical Trials, 2021 3. Smoking Cessation Phase 1 Clinical Trials, 2021 ResearchAndMarkets.com is the world's leading ...
Meet Two Doctors Fighting for BIPOC Representation in Clinical Trials
on January 18, 2021
Below, Dr. Corado and Dr. Currier explain why it is important to have more BIPOC representation in clinical trials. Well+Good: How are communities of color disproportionately impacted by the COVID-19 ...
Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson’s Disease in Humans
on January 15, 2021
Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).
Clinical Trial Packaging Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2025
on January 15, 2021
The global Clinical Trial Packaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected ...
Lifespan to participate in Novavax COVID-19 vaccine clinical trial
on January 14, 2021
Lifespan is seeking volunteers to enroll in a Phase 3 safety and efficacy trial of a new COVID-19 vaccine being developed by Novavax, a Maryland-based company. The Brown-affiliated healthcare system ...
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled
on January 14, 2021
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced its ongoing U.S. Phase I ...
Large Clinical Trial Testing Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19
on January 12, 2021
A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild or moderate COVID-19. The two ...